Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Motif Bio, Lamellar Agree to Test New Therapeutic Combo for CF Lung Infections Motif Bio, Lamellar Agree to Test New Therapeutic Combo for CF Lung Infections May 07, 2019 07:00 am | Joana Carvalho Motif Bio has entered an agreement with Lamellar Biomedical to undertake a preclinical study that will test a new therapeutic combination for treating lung infections in patients with cystic fibrosis (CF). Under the terms of the agreement, Motif Bio will launch a preclinical study to assess the effectiveness of the company’s investigational broad spectrum antibiotic iclaprim […] The post Motif Bio, Lamellar Agree to Test New Therapeutic Combo for CF Lung Infectionsappeared first on Cystic Fibrosis News Today. Read More   Recent News How to Love Your Body, Even If It’s Genetically Abnormal Researcher Will Use $3.3M NIH Grant to Develop ‘One-Size-Fits-All’ Inhaled Therapy Help! I’m Haunted by Old Photos of My Health Emily’s Entourage to Host 4th Annual EENY: Ultra Violet CF Fundraiser May 4 Being Brave and Making a Meaningful Connection